City Therapeutics, Inc. Common Stock Net Asset Quality Index
City Therapeutics, Inc. Common Stock net asset quality index. City Therapeutics, Inc. Common Stock (CTY) has a Net Asset Quality Index of -63.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $208.61 Million minus total liabilities of $340.33 Million yields net assets of $-131.72 Million. A higher index indicates a stronger, lower-leverage balance sheet. See City Therapeutics, Inc. Common Stock shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of City Therapeutics, Inc. Common Stock (2006–2025)
Net asset quality index of City Therapeutics, Inc. Common Stock from 2006 to 2025. This chart shows how City Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 16 annual periods from 2006 to 2025. As of June 2026, the index stands at -63.1%, representing net assets of $-131.72 Million against total assets of $208.61 Million USD. Check CTY tangible net worth ratio to evaluate the tangible quality of the company's equity base.
City Therapeutics, Inc. Common Stock Net Asset Quality Index by Year (2006–2025)
City Therapeutics, Inc. Common Stock net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for City Therapeutics, Inc. Common Stock from 2006 to 2025, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of City Therapeutics, Inc. Common Stock.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -56.5% | $-84.66 Million | $149.77 Million | $234.42 Million | ▼ -36.3 pp |
| 2024 | -20.2% | $-29.43 Million | $145.35 Million | $174.78 Million | ▼ -68.4 pp |
| 2019 | 48.2% | $10.12 Billion | $21.00 Billion | $10.88 Billion | ▲ +0.2 pp |
| 2018 | 47.9% | $9.87 Billion | $20.58 Billion | $10.71 Billion | ▲ +3.2 pp |
| 2017 | 44.7% | $9.34 Billion | $20.87 Billion | $11.53 Billion | ▲ +3.6 pp |
| 2016 | 41.1% | $8.69 Billion | $21.15 Billion | $12.46 Billion | ▼ -0.4 pp |
| 2015 | 41.5% | $8.91 Billion | $21.47 Billion | $12.56 Billion | ▲ +0.6 pp |
| 2014 | 40.9% | $9.18 Billion | $22.46 Billion | $13.27 Billion | ▲ +25.9 pp |
| 2013 | 15.0% | $2.40 Billion | $16.01 Billion | $13.61 Billion | ▼ -1.4 pp |
| 2012 | 16.4% | $2.74 Billion | $16.71 Billion | $13.97 Billion | ▲ +2.9 pp |
| 2011 | 13.5% | $2.35 Billion | $17.39 Billion | $15.04 Billion | ▲ +6482.3 pp |
| 2010 | -6468.8% | $-14.30 Billion | $221.00 Million | $14.52 Billion | ▼ -5304.7 pp |
| 2009 | -1164.0% | $-13.56 Billion | $1.17 Billion | $14.73 Billion | ▲ +3510.2 pp |
| 2008 | -4674.3% | $-14.35 Billion | $307.00 Million | $14.66 Billion | ▼ -2714.3 pp |
| 2007 | -1960.0% | $-13.72 Billion | $700.00 Million | $14.42 Billion | ▼ -1960.7 pp |
| 2006 | 0.7% | $110.00 Million | $14.85 Billion | $14.74 Billion | — |